Array Biopharma Inc (ARRY) Given a $14.00 Price Target at Piper Jaffray Companies

Array Biopharma Inc (ARRY) Given a $14.00 Price Target at Piper Jaffray Companies


The firm presently has a "buy" rating on the biopharmaceutical company's stock. Piper Jaffray Companies' price target suggests a potential upside of 80.88% from the stock's previous close.



from Biotech News